×

Diketopiperazine microparticles with defined specific surface areas

  • US 8,778,403 B2
  • Filed: 09/03/2013
  • Issued: 07/15/2014
  • Est. Priority Date: 06/12/2009
  • Status: Active Grant
First Claim
Patent Images

1. A method of delivering an active agent to a patient in need thereof comprising administering a dry powder comprising microparticles of a diketopiperazine, the microparticles having a specific surface area of about 40 m2/g to 67 m2/g, the microparticles having been loaded with a drug or active agent, by inhalation of said dry powder by said patient.

View all claims
  • 5 Assignments
Timeline View
Assignment View
    ×
    ×